CSL Seqirus, a business of CSL (ASX: CSL), today announced a real-world evidence (RWE) study recently published in Open Forum Infectious Diseases (OFID), showing that a cell-based quadrivalent ...

Duke researchers have opened a new avenue in the attack against influenza viruses by creating a vaccine that encourages the ...

A schematic diagram of the influenza virus, showing the surface proteins hemagglutinin (blue, peanut shaped) and ...

Experimental vaccine targets portions of the flu virus that don’t change. Duke researchers have opened a new avenue in the ...

The study suggests that cell-based quadrivalent influenza vaccine (QIVc) may have the potential to be more effective than egg-based vaccines (QIVe) in preventing test-confirmed influenza.

Yearly administration of the influenza vaccine is the main strategy to prevent influenza in immunocompromised patients. Here, we reviewed the recent literature regarding the clinical significance ...

2023 — Recent preclinical results indicate novel next-generation vaccine candidates protect against multiple strains of influenza and last longer than vaccines currently in ... Coronavirus ...

(RTTNews) - CSL Seqirus, a subsidiary of CSL Ltd. (CSL.AX), Thursday said that a real-world evidence study shows that a cell-based quadrivalent influenza vaccine has been more effective than an ...

Researchers compared the disease severity of unvaccinated adults hospitalized with RSV with that of vaccinated and unvaccinated inpatients with COVID-19 and influenza.

Duke researchers have opened a new avenue in the attack against influenza viruses by creating a vaccine that encourages the immune system to target a portion of the virus surface that is less ...